Ogorek Anthony Joseph’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.06M | Buy |
104,515
+299
| +0.3% | +$28.6K | 2.48% | 12 |
|
|
2025
Q4 | $10M | Hold |
104,216
| – | – | 2.75% | 13 |
|
|
2025
Q3 | $9.93M | Buy |
104,216
+6
| +0% | +$552 | 2.84% | 13 |
|
|
2025
Q2 | $9.08M | Hold |
104,210
| – | – | 2.81% | 13 |
|
|
2025
Q1 | $9.36M | Hold |
104,210
| – | – | 3.08% | 11 |
|
|
2024
Q4 | $8.32M | Buy |
104,210
+101,629
| +3,938% | +$8.8M | 2.65% | 11 |
|
|
2024
Q3 | $232K | Hold |
2,581
| – | – | 0.08% | 57 |
|
|
2024
Q2 | $203K | Sell |
2,581
-167
| -6% | -$13.7K | 0.07% | 58 |
|
|
2024
Q1 | $239K | Sell |
2,748
-105
| -4% | -$8.96K | 0.08% | 53 |
|
|
2023
Q4 | $235K | Hold |
2,853
| – | – | 0.09% | 55 |
|
|
2023
Q3 | $223K | Hold |
2,853
| – | – | 0.09% | 72 |
|
|
2023
Q2 | $251K | Sell |
2,853
-205
| -7% | -$17.6K | 0.1% | 66 |
|
|
2023
Q1 | $246K | Hold |
3,058
| – | – | 0.1% | 66 |
|
|
2022
Q4 | $237K | Hold |
3,058
| – | – | 0.1% | 56 |
|
|
2022
Q3 | $246K | Hold |
3,058
| – | – | 0.12% | 54 |
|
|
2022
Q2 | $274K | Hold |
3,058
| – | – | 0.13% | 53 |
|
|
2022
Q1 | $339K | Hold |
3,058
| – | – | 0.14% | 51 |
|
|
2021
Q4 | $316K | Hold |
3,058
| – | – | 0.14% | 48 |
|
|
2021
Q3 | $383K | Hold |
3,058
| – | – | 0.17% | 41 |
|
|
2021
Q2 | $379K | Hold |
3,058
| – | – | 0.17% | 42 |
|
|
2021
Q1 | $361K | Buy |
3,058
+105
| +4% | +$12.3K | 0.18% | 37 |
|
|
2020
Q4 | $345K | Hold |
2,953
| – | – | 0.18% | 32 |
|
|
2020
Q3 | $306K | Sell |
2,953
-594
| -17% | -$59.7K | 0.18% | 30 |
|
|
2020
Q2 | $325K | Buy |
3,547
+167
| +5% | +$16K | 0.23% | 22 |
|
|
2020
Q1 | $304K | Hold |
3,380
| – | – | 0.17% | 23 |
|
|
2019
Q4 | $383K | Sell |
3,380
-1,795
| -35% | -$197K | 0.19% | 24 |
|
|
2019
Q3 | $562K | Sell |
5,175
-790
| -13% | -$82.4K | 0.34% | 15 |
|
|
2019
Q2 | $580K | Hold |
5,965
| – | – | 0.39% | 14 |
|
|
2019
Q1 | $543K | Hold |
5,965
| – | – | 0.36% | 14 |
|
|
2018
Q4 | $542K | Buy |
5,965
+100
| +2% | +$9.35K | 0.43% | 14 |
|
|
2018
Q3 | $576K | Buy |
5,865
+494
| +9% | +$45.7K | 0.42% | 15 |
|
|
2018
Q2 | $459K | Hold |
5,371
| – | – | 0.36% | 15 |
|
|
2018
Q1 | $430K | Hold |
5,371
| – | – | 0.37% | 16 |
|
|
2017
Q4 | $433K | Sell |
5,371
-2,829
| -35% | -$227K | 0.35% | 13 |
|
|
2017
Q3 | $637K | Hold |
8,200
| – | – | 0.62% | 9 |
|
|
2017
Q2 | $727K | Hold |
8,200
| – | – | 0.67% | 9 |
|
|
2017
Q1 | $660K | Hold |
8,200
| – | – | 0.68% | 8 |
|
|
2016
Q4 | $708K | Hold |
8,200
| – | – | 0.61% | 9 |
|
|
2016
Q3 | $708K | Hold |
8,200
| – | – | 0.61% | 9 |
|
|
2016
Q2 | $711K | Hold |
8,200
| – | – | 0.64% | 8 |
|
|
2016
Q1 | $615K | Sell |
8,200
-20,000
| -71% | -$1.51M | 0.5% | 8 |
|
|
2015
Q4 | $2.17M | Sell |
28,200
-5,000
| -15% | -$376K | 1.81% | 9 |
|
|
2015
Q3 | $2.22M | Hold |
33,200
| – | – | 1.82% | 9 |
|
|
2015
Q2 | $2.46M | Hold |
33,200
| – | – | 1.89% | 9 |
|
|
2015
Q1 | $2.59M | Hold |
33,200
| – | – | 1.78% | 9 |
|
|
2014
Q4 | $2.4M | Buy |
+33,200
| New | +$2.31M | 1.8% | 10 |
|
Other funds holding MDT
VCM
VPM
Ogorek Anthony Joseph's MDT Position: Q1 2026 in Review
Ogorek Anthony Joseph increased its Medtronic (MDT) stake by 0.29% in Q1 2026, buying an estimated $28.6K and bringing the position to 104,515 shares worth $9.06M. The position accounts for 2.48% of the portfolio, ranked #12.
Ogorek Anthony Joseph first reported a position in MDT in Q4 2014 and has held it in 46 quarters since. The position peaked at $10M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Ogorek Anthony Joseph held 104,515 shares of Medtronic worth $9.06M as of Q1 2026.
- Ogorek Anthony Joseph bought 299 Medtronic shares in Q1 2026, an estimated $28.6K.
- Medtronic made up 2.48% of Ogorek Anthony Joseph's portfolio in Q1 2026, its #12 holding.
- Ogorek Anthony Joseph first reported a position in Medtronic in Q4 2014 and has held it in 46 quarters since.
- Ogorek Anthony Joseph's Medtronic position peaked at $10M in Q4 2025.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Ogorek Anthony Joseph's 13F filing for Q1 2026, filed 11 May 2026.